COVID-19, flu shots might raise stroke risk for older Americans: Preprint

The risk of a stroke was more prevalent for older adults who received a flu and bivalent COVID-19 vaccine within six weeks of the other in fall 2022, according to a preprint of research conducted by the FDA and CMS. 

Advertisement

Researchers evaluated the stroke risk among more than 5 million Medicare beneficiaries aged 65 and older. They found that, between Aug. 31 and Nov. 6, 2022, those who received a bivalent COVID-19 shot and a high-dose flu vaccine had a slightly higher stroke risk than those who were only vaccinated for COVID-19. 

There was not an increased risk of stroke among older adults who only received a bivalent COVID-19 shot, according to the study that is waiting on peer review.  

Those who received Pfizer’s COVID-19 vaccine and a flu vaccine saw a 20% increase in the risk of transient ischemic stroke, and those who got a Moderna COVID-19 vaccine and flu shot saw a 35% increased risk. 

This outcome is more likely to be tied to the influenza shot, the researchers concluded: “The observed risk of stroke in the concomitant subgroup was likely driven by influenza vaccination alone rather than concomitant administration [a COVID-19 vaccine administration].”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.